A Comparative Clinical Evaluation Of Katphaladi Churna And Pippalyadi Churna In Management Of Tamaka Swasa

Abstract

Since time immemorial man has been in constant endeavor to find the solutions for the life threatening and agonizing disorders, which afflicts the human race. One of such condition is ‘Tamaka swasa’ which is known by the name Bronchial Asthma in modern parlance, wherein remissions and exacerbations are the typical features, leaving the patient in pathetic situation. The Objective of the study is to evaluate the comparative efficacy of Katphaladi Churna and Pippalyadi Churna in the management of Tamaka Swasa through subjective and objective parameter. Present study registers 40 out of 64 patients. Out of these 24 patients were discontinued. The remaining 40 patients of Tamaka Swasa fulfilling the criteria of diagnosis and inclusive criteria were included in the study, fewer than two group as distributed patients in Group–A are 20 patients and Group–B are 20 patients. While comparing between the group result shows that Pippalyadi Churna is statistically more effective in Swasa Krichrata, Pratishaya, Kanthodavamsa and AEC than the Katphaladi Churna. In overall result Pippalyadi Churna is more effective than the Katphaladi Churna in the management of Tamaka Swasa. Both of the trial drugs proved to be a safe and effective oral formulation, which helps in the management of Tamaka swasa, when the disease is not too advanced and not associated with complications also when correctly used by the patient as per instructions.